Feasibility of voxel-based Dose Painting for recurrent Glioblastoma guided by ADC values of Diffusion-Weighted MR imaging-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Feasibility of voxel-based Dose Painting for recurrent Glioblastoma guided by ADC values of Diffusion-Weighted MR imaging

Published:2016-12 Issue:12 Volume:32 Page:1651-1658
ISSN:1120-1797
Container-title:Physica Medica
language:en
Short-container-title:Physica Medica

Author:

Orlandi M.,Botti A.,Sghedoni R.,Cagni E.,Ciammella P.,Iotti C.,Iori M.

Publisher

Elsevier BV

Subject

General Physics and Astronomy,Radiology, Nuclear Medicine and imaging,General Medicine,Biophysics

Reference29 articles.

1. Radiotherapy plus concomitant and adjuvant Temozolomide for Gliobalstoma;Stupp;N Engl J Med,2005

2. Hypofractionated stereotactic radiation therapy for recurrent Glioblastoma: single institutional experience;Ciammella;Radiat Oncol,2013

3. Patterns of failure for Glioblastoma Multiforme following limited-margin radiation and concurrent Temozolomide;Gebhardt;Radiother Oncol,2014

4. Phase 2 trial of hypofractionated high-dose Intensity Modulated Radiation Therapy with concurrent and adjuvant Temozolomide for newly diagnosed Glioblastoma;Iuchi;Int J Radiat Oncol Biol Phys,2014

5. Toward patient-specific, biologically optimized radiation therapy plans for the treatment of Glioblastoma;Corwin;PLoS ONE,2013

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of geometric correction on echo-planar imaging-based apparent diffusion coefficient maps for abdominal radiotherapy;Biomedical Physics & Engineering Express;2024-09-11

2. Incidence, mortality, and survival of hematological malignancies in Northern Italian patients: an update to 2020;Frontiers in Oncology;2023-07-18

3. Isotoxic dose escalated radiotherapy for glioblastoma based on diffusion-weighted MRI and tumor control probability—an in-silico study;The British Journal of Radiology;2023-06-01

4. Majoration de dose d’irradiation pour les glioblastomes;Cancer/Radiothérapie;2022-10

5. Safety of Inhomogeneous Dose Distribution IMRT for High-Grade Glioma Reirradiation: A Prospective Phase I/II Trial (GLIORAD TRIAL);Cancers;2022-09-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3